BioSpace News Archive

Allina Health and Aetna have named Tom Lindquist as CEO of Allina Health and Aetna Insurance Company the jointly owned health care company that was announced by the two organizations in January 2017.

US WorldMeds announced that the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 11 to 1 to recommend approval of lofexidine for mitigating opioid withdrawal symptoms.

BioAmber Inc. announced operational and financial results for the three months and year ended December 31, 2017.

PMD Healthcare has released top-line findings from their 2018 Cystic Fibrosis and Pulmonary Fibrosis online surveys.

Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery systems

Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, today announced that it has successfully secured a US$60 million Series A+ financing round led by Green Pine Capital Partners and Prosperico Ventures with participation from new and existing investors,

The U.S. Food and Drug Administration today permitted marketing of the DexCom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes.

Impax Laboratories, Inc. announced that at its special meeting of stockholders held today, Impax stockholders overwhelmingly approved the previously announced business combination of Impax with Amneal Pharmaceuticals LLC.

DexCom, Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Dexcom G6® CGM System, the newest generation of CGM for people with diabetes ages 2 and up.

Tetra Bio-Pharma Inc. is pleased to announce it has closed its non-brokered private placement of 4,292,000 units at a price of $1.00 per unit for aggregate gross proceeds of $4,292,000.